Saito Hirokazu, Koga Takehiko, Sakaguchi Masafumi, Kadono Yoshihiro, Kamikawa Kentaro, Urata Atsushi, Imamura Haruo, Tada Shuji, Kakuma Tatsuyuki, Matsushita Ikuo
Department of Gastroenterology, Kumamoto Chuo Hospital, Japan.
Department of Gastroenterology, Saiseikai Kumamoto Hospital, Japan.
Intern Med. 2019 Aug 1;58(15):2125-2132. doi: 10.2169/internalmedicine.2546-18. Epub 2019 Apr 17.
Objective We examined the safety and efficacy of endoscopic stone removal for choledocholithiasis in elderly patients ≥90 years of age with native papilla and compared the outcomes with those in patients 75-89 years of age. Methods This multicenter retrospective study included 569 patients 75-89 years of age and 126 patients ≥90 years of age who had native papilla and underwent therapeutic endoscopic retrograde cholangiopancreatography (ERCP) for choledocholithiasis at 3 institutions in Japan between April 2012 and March 2018. The main outcomes assessed were the incidence of post-ERCP complications during hospitalization and outcomes of ERCP in patients ≥90 years of age. Results Biliary cannulation and subsequent endoscopic sphincterotomy, endoscopic balloon dilation, and endoscopic large balloon dilation were successful in 97.7% of patients 75-89 years of age and in 98.4% of patients ≥90 years of age. There was no significant difference in the incidence of post-ERCP complications between patients 75-89 years of age and those ≥90 years of age (7.7% vs. 9.5%, respectively; p=0.47). Although the rate of use of mechanical lithotripter was not significantly different, the rate of complete stone removal in patients ≥90 years of age was lower than that in patients 75-89 years of age (81.0% vs. 94.9%, respectively; p<0.001). In all cases with incomplete stone removal in both groups, permanent biliary stent placement was successful. Conclusion ERCP for choledocholithiasis in elderly patients ≥90 years of age is a safe and effective procedure; however, endoscopists should select appropriate strategies after considering each patient's medical condition and background.
目的 我们研究了内镜下取石术治疗90岁及以上具有天然乳头的老年胆总管结石患者的安全性和有效性,并将结果与75 - 89岁患者进行比较。方法 这项多中心回顾性研究纳入了2012年4月至2018年3月间在日本3家机构接受治疗性内镜逆行胰胆管造影术(ERCP)治疗胆总管结石的569例75 - 89岁患者和126例90岁及以上具有天然乳头的患者。评估的主要结局是住院期间ERCP后并发症的发生率以及90岁及以上患者的ERCP结局。结果 75 - 89岁患者中97.7%、90岁及以上患者中98.4%成功完成胆管插管及随后的内镜下括约肌切开术、内镜下球囊扩张术和内镜下大球囊扩张术。75 - 89岁患者与90岁及以上患者ERCP后并发症发生率无显著差异(分别为7.7%和9.5%;p = 0.47)。尽管机械碎石器的使用率无显著差异,但90岁及以上患者结石完全清除率低于75 - 89岁患者(分别为81.0%和94.9%;p < 0.001)。两组结石清除不完全的所有病例中,永久性胆管支架置入均成功。结论 90岁及以上老年患者行ERCP治疗胆总管结石是一种安全有效的方法;然而,内镜医师应在考虑每位患者的病情和背景后选择合适的策略。